SLC7A2: A Drug Target and Biomarker for wastewater treatment and energy production

Target Name: SLC7A2

NCBI ID: G6542

SLC7A2

SLC7A2: A Drug Target and Biomarker for wastewater treatment and energy production

SLC7A2 is a protein belonging to Solute Carrier Family 7 and has important biological functions in organisms. As a transmembrane protein, SLC7A2 plays a key role in many physiological processes, including energy metabolism, waste discharge, and cell signaling. In the field of wastewater treatment, SLC7A2 is also regarded as a potential drug target or biomarker. This article will introduce the role, discovery and application of SLC7A2 in wastewater treatment and energy production.

The role of SLC7A2

SLC7A2 is a protein expressed in many different cell types. It plays a variety of biological functions within cells, including transporting substances, maintaining cell shape, and participating in cell signaling and energy metabolism. SLC7A2 plays an important role in energy metabolism. It is a protein on the inner membrane of mitochondria and a key component of the respiratory chain on the inner membrane of mitochondria. SLC7A2 helps cells generate energy by participating in electron transfer in the respiratory chain.

SLC7A2 is also very important in waste emissions. SLC7A2 is responsible for transporting and excreting a variety of waste products within cells, including amino acids and urea. Accumulation of these waste products within cells reduces cell function and increases cell death. SLC7A2's role in waste excretion also makes it a potential biomarker for detecting diseases such as kidney disease and liver disease.

Discovery of SLC7A2

The discovery of SLC7A2 stemmed from research into disease and wastewater treatment. Because SLC7A2 is expressed in many different cell types, it is considered a potential drug target or biomarker. Researchers discovered SLC7A2 through gene knockout technology and protein isolation and purification. In addition, the expression level of SLC7A2 can also be used as an online monitoring indicator in sewage treatment plants.

Application of SLC7A2 in sewage treatment

SLC7A2 is widely used in sewage treatment. Since SLC7A2 is expressed in many different cell types, it can serve as a transmembrane protein and be used as a selective removal agent in wastewater treatment. SLC7A2 can combine with organic matter in sewage treatment to achieve the purpose of removing organic matter and improving sewage treatment efficiency.

SLC7A2 applications in energy production

SLC7A2 also plays an important role in energy production. SLC7A2 participates in electron transfer in the respiratory chain on the inner mitochondrial membrane and is a key component of cells producing energy. In addition, SLC7A2 can also participate in fatty acid metabolism within cells, thereby providing energy to cells. Therefore, SLC7A2 is regarded as a potential bioenergy metabolite.

SLC7A2 applications in wastewater treatment and energy production

SLC7A2 has a wide range of applications in wastewater treatment and energy production. SLC7A2 can be used as a remover for sewage treatment. The protein structure of SLC7A2 can be used as a drug target to treat a variety of diseases. SLC7A2 can also serve as a bioenergy metabolite, providing energy to cells.

Protein Name: Solute Carrier Family 7 Member 2

Functions: Functions as permease involved in the transport of the cationic amino acids (arginine, lysine and ornithine); the affinity for its substrates differs between isoforms created by alternative splicing (PubMed:9174363). May play a role in classical or alternative activation of macrophages via its role in arginine transport (By similarity)

The "SLC7A2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC7A2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets